Laboratorio de fabricación y desarrollo de medicamentos
Project PX-0915A What We’re Working On
At PanAmFarma, We are continuously advancing our mission to make high-quality specialty pharmaceuticals more accessible across Latin America. Project PX-0915A
Our current R&D and regulatory focus is Project PX-0915A, a next-generation biosimilar initiative centered on one of the most widely prescribed biologic therapies in chronic disease management.
PX-0915A is a proprietary formulation project designed to meet the therapeutic needs of both public and private healthcare systems. In collaboration with academic researchers and licensed manufacturing partners, we are currently engaged in the formulation, analytical characterization, and early regulatory alignment phases. The objective: to bring a highly effective, cost-accessible biosimilar to market in compliance with COFEPRIS and regional regulatory standards.
This development effort aligns with PanAmFarma’s long-term strategy to build a robust, Latin America–focused biosimilars pipeline addressing unmet clinical needs and supporting sovereign pharmaceutical capacity across the region.
If you are a licensed importer, wholesaler, or public-sector procurement agency seeking strategic access to future biologics and biosimilars, we invite you to connect with our Business Development team regarding upcoming opportunities.
📩 Contact: info@panamfarma.com
📞 Tel.: +52 322 308 0021 | +1 713 322 9272
🌐 WhatsApp: +1 409 789 9957
